• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Sequana Medical AG

CMS proposes approval of additional payment for Sequana Alfapump

April 14, 2025 By Sean Whooley

Sequana Medical announced today that CMS recommended that its Alfapump system become eligible for a new incremental payment. Alfapump treats these fluid overload conditions that arise due to liver cirrhosis and malignant ascites. The fully implantable, wirelessly charged device continuously collects ascites as it forms in the abdominal cavity. It then moves into the bladder, […]

Filed Under: Blood Management, Implants, Urology Tagged With: Centers for Medicare and Medicaid Services (CMS), Reimbursement, Sequana Medical AG

1,000th implant completed with Sequana Alfapump for treating fluid overload

July 7, 2023 By Sean Whooley

Sequana Medical announced that it implanted the 1,000th implant of its Alfapump for treating recurrent and refractory ascites. The Ghent, Belgium-based company’s pump treats these fluid overload conditions that arise due to liver cirrhosis and malignant ascites. In addition to the milestone implant, Sequana said it received all administrative clearances to begin its U.S. MOJAVE […]

Filed Under: Blood Management, Business/Financial News, Cardiovascular, Implants, Vascular Tagged With: Sequana Medical AG

Sequana Medical lands IDE approval for abdominal pump trial

June 5, 2019 By Nancy Crotti

Sequana Medical said it has received investigational device exemption approval from the FDA to conduct a pivotal study of its Alfapump device for patients with recurrent or refractory ascites due to liver cirrhosis. Alfapump is a fully implantable pump designed to continuously remove excess abdominal fluid in patients with liver disease. Zurich-based Sequana has applied to […]

Filed Under: Clinical Trials, Featured, News Well Tagged With: FDA, Health Canada, Sequana Medical AG

Xtant Medical CEO Goldberger steps down | Personnel Moves | February 3, 2017

February 3, 2017 By Brad Perriello

Xtant Medical (NYSE:XTNT) said that CEO Dan Goldberger resigned effective Jan. 21 “to pursue other interests.” The Belgrade, Mont.-based company, which was formed after Bacterin paid $86 million for spinal implant maker X-Spine Systems, said president Carl O’Connell will step in as interim CEO while the company’s board “contemplates the permanent CEO,” according to a […]

Filed Under: Business/Financial News Tagged With: AdvaMed, Guided Therapeutics Inc., Personnel Moves, reflexion-health, ResMed Inc., Sequana Medical AG, Spectranetics Corp., Titan Spine, Valeritas, Xtant Medical

Burberry poaches Smith & Nephew CFO Brown | Personnel Moves for July 12, 2016

July 12, 2016 By Brad Perriello

Burberry poaches Smith & Nephew CFO Brown Smith & Nephew (NYSE:SNN) said yesterday that CFO Julie Brown is leaving the company in January 2017 after 4 years on the job at the British healthcare products giant. Brown, who was named finance chief in November 2012 and assumed the role in February 2013, is moving to […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News Tagged With: Air Techniques, Cogentix Medical, DDS Lab, Pelvalon, Personnel Moves, Sequana Medical AG, Smith & Nephew

Sequana Medical adds $9m for Alfapump implantable pump

October 23, 2015 By Brad Perriello

Sequana Medical said today that it added $9.3 million to the $26 million Series C round it raised last year, as it readies for a U.S. clinical trial of its Alfapump implantable pump. Zurich-based Sequana said existing backers NeoMed Management, VI Partners, Biomed Invest, Capricorn Health-tech Fund, Entrepreneurs Fund and Life Science Partners put up $5.5 million. New investors […]

Filed Under: Clinical Trials, Implants Tagged With: Sequana Medical AG

SI-Bone announces big plans for its newly raised $33 million | Medtech funding stories for the week of Apr. 28, 2014

May 2, 2014 By MassDevice Contributors Network Leave a Comment

SI-Bone has big plans for newly raised $33M

April 30, 2014 by Arezu Sarvestani

SI-Bone raises $33M for minimally invasive fusion system

Filed Under: Funding Roundup, News Well Tagged With: Sequana Medical AG, SiBone, Stryker

Funding: Sequana raises $26.2M for implantable bladder pump

April 28, 2014 By Arezu Sarvestani Leave a Comment

Funding: Sequana raises $26.2M for implantable bladder pump

Switzerland-based medtech company Sequana Medical has big plans for its newly-closed $26.2 million (CHF 23 million) Series C financing round, hoping to use the funds to widen its global sales and begin penetrating the U.S. market.

Filed Under: Funding Roundup, Implants, News Well Tagged With: Sequana Medical AG

St. Jude’s Ilumien hybrid wins CE Mark | Regulatory Roundup

July 14, 2011 By MassDevice staff Leave a Comment

Regulatory Roundup

St. Jude Medical Inc. (NYSE:STJ) landed CE Mark approval in the European Union for what it bills as the first and only hybrid diagnostic imaging system to combine optical coherence tomography and fractional flow reserve technology into a single platform.

Filed Under: News Well Tagged With: ActiViews Inc., Edwards Lifesciences, Guided Therapeutics Inc., NovaShunt AG, Sequana Medical AG, stjudemedical

Health care: Obama’s insurance mandate gets mixed reception in court

June 2, 2011 By MassDevice staff Leave a Comment

MassDevice On Call

MASSDEVICE ON CALL — A panel of federal appellate judges heard arguments yesterday regarding President Barack Obama’s health care overhaul to determine whether the administration can constitutionally require citizens to buy health insurance.

During 90 minutes of oral arguments, the three-member panel of judges gave both the administration and its challengers a mixed reception.

Two judges on the three-member panel were appointed by Republican presidents.

Filed Under: Healthcare Reform, Medicare, News Well, Research & Development Tagged With: NovaShunt AG, Sequana Medical AG

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy